Thanks redant
As for investors we can assume that a CR WILL happen as stated
" The financial model assumes a capital raising in FY21 of AUD15m. The amount should provide sufficient funding to undertake the Phase II trial. The financial model assumes PAT-DX1 will be licensed during this period, with the partner assuming on-going development costs. "
I will also assume that when, if, we get an announcement on licensing of PAT-DX1 this will leave us with a sp very close to 5c..............I initially did worry that a cr might be needed sooner rather than in FY21 and a CR at 2c or even 3c will do us more harm than good. I can see a concerted effort for BOD to get sp closer to 5c before embarking on a CR as at that time soooooooooooooooo much more risk would have been removed and sentiment will be 100% higher than today
LT view required
GLTA
- Forums
- ASX - By Stock
- PAB
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-18
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $620 | 88.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 5809153 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1618945 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 5809153 | 0.006 |
16 | 7030776 | 0.005 |
7 | 4425000 | 0.004 |
5 | 2730016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1618945 | 3 |
0.008 | 2057547 | 3 |
0.009 | 133332 | 1 |
0.010 | 1592000 | 4 |
0.011 | 1080000 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |